au.\*:("Toulouse Clinical Investigation Centre")
Results 1 to 11 of 11
Selection :
DyskinesiasMovement disorders. 1999, Vol 14, issn 0885-3185, 82 p., SUP1Conference Proceedings
Neurosurgical treatment of dyskinesias : Pathophysiological considerationPOLLAK, P.Movement disorders. 1999, Vol 14, pp 33-39, issn 0885-3185, SUP1Conference Paper
Rating scales for dyskinesias in Parkinson's diseaseGOETZ, C. G.Movement disorders. 1999, Vol 14, pp 48-53, issn 0885-3185, SUP1Conference Paper
L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease : A clinical pharmacologic approachRASCOL, O.Movement disorders. 1999, Vol 14, pp 19-32, issn 0885-3185, SUP1Conference Paper
Dyskinesias assessment : From CAPIT to CAPSITWIDNER, H; DEFER, G.-L.Movement disorders. 1999, Vol 14, pp 60-66, issn 0885-3185, SUP1Conference Paper
Dyskinesias assessment and ambulatory devicesBROWN, P; MANSON, A.Movement disorders. 1999, Vol 14, pp 67-68, issn 0885-3185, SUP1Conference Paper
L-dopa and dyskinesias in normal monkeysPEARCE, R. K. B.Movement disorders. 1999, Vol 14, pp 9-12, issn 0885-3185, SUP1Conference Paper
Quantitative assessment of dyskinesias in subhuman primatesBROTCHIE, J. M; FOX, S. H.Movement disorders. 1999, Vol 14, pp 40-47, issn 0885-3185, SUP1Conference Paper
The phenomenology of L-dopa-induced dyskinesias in Parkinson's diseaseVIDAILHET, M; BONNET, A. M; MARCONI, R et al.Movement disorders. 1999, Vol 14, pp 13-18, issn 0885-3185, SUP1Conference Paper
Dyskinesias assessment in phase II studiesDAMIER, P; JAILLON, C; CLAVIER, I et al.Movement disorders. 1999, Vol 14, pp 54-59, issn 0885-3185, SUP1Conference Paper
Pathophysiology of L-Dopa-induced dyskinesiasBEDARD, P. J; BLANCHET, P. J; DOUCET, J.-P et al.Movement disorders. 1999, Vol 14, pp 4-8, issn 0885-3185, SUP1Conference Paper